p. 5653 - 5660
(2007/10/02)p. 192 - 197
(2007/10/02)p. 441 - 442
(2007/10/02)Formic acid (4aR,4bS,8aR,10aR)-7-[1-butylsulfanyl-meth-(Z)-ylidene]-1,1,4a-trimethyl-8-oxo-tetradecahydro-phenanthren-2-yl ester
tert-Butyl-dimethyl-((2S,4aR,4bS,10aR)-1,1,4a,7-tetramethyl-7-vinyl-1,2,3,4,4a,4b,5,6,7,9,10,10a-dodecahydro-phenanthren-2-yloxy)-silane
(+/-) - 3α-t-butyldimethylsilyloxy-13-formyl-4α,4β,10α-trimethyl-1,2,3,4,5β,6,7,8α,9β,10,11,12-dodecahydrophenanthrene
(+/-) - 3α-t-butyldimethylsilyloxy-13-formyl-4α,4β,10α,13-tetramethyl-1,2,3,4,5β,6,7,9β,10,11,12,13-dodecahydrophenanthrene
(+/-) - 3α-t-butyldimethylsilyloxy-13-butylthiomethylene-4α,4β,10α-trimethyl-14 oxo-5β,8α,9β-perhydrophenanthrene
(S)-3,3,3-Trifluoro-2-methoxy-2-phenyl-propionic acid (2S,4aR,4bS,7R,10aR)-1,1,4a,7-tetramethyl-7-vinyl-1,2,3,4,4a,4b,5,6,7,9,10,10a-dodecahydro-phenanthren-2-yl ester
oryzalexin C
oryzalexin B
(S)-3,3,3-Trifluoro-2-methoxy-2-phenyl-propionic acid (2R,4aS,4bR,7S,10aS)-1,1,4a,7-tetramethyl-7-vinyl-1,2,3,4,4a,4b,5,6,7,9,10,10a-dodecahydro-phenanthren-2-yl ester
(+/-)-3β,7α-dihydroxyisopimara-8(14),15-diene